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Introduction
Cardiac output monitoring in the critically ill patient is 
standard practice in order to ensure tissue oxygenation 
[1] and has been traditionally accomplished using the 
pulmonary artery catheter (PAC). In recent years, 
however, the value of PAC has been questioned with 
some suggesting that its use might not only be un-
necessary but also potentially harmful [1]. Th  is notion, 
together with the availability of new less invasive cardiac 
output measuring devices, has markedly decreased the 
widespread use of the PAC [2]. Today, various devices are 
available to measure or estimate cardiac output using 
diﬀ  erent methods. Some of these less invasive devices 
track stroke volume (SV) continuously and provide 
dynamic indices of ﬂ   uid responsiveness, others allow 
assessment of volumetric preload variables, and some 
also provide continuous measurement of central venous 
saturation via the use of proprietary catheters that are 
attached to the same monitor. All these variables – 
together with cardiac output – may result in an improved 
hemodynamic assessment of the critically ill patient. 
However, it is important to appreciate that each device 
has its inherent limitations and that no cardiac output 
monitoring device can change patient outcome unless its 
use is coupled with an intervention that by itself has been 
associated with improved patient outcomes. Th  erefore, 
the concept of hemodynamic optimization is increasingly 
recognized as a cornerstone in the management of 
critically ill patients and has been shown to be associated 
with improved outcome in the perioperative [3] and in 
the intensive care unit (ICU) [4] setting.
Th  e aim of this article is to provide a systematic up-
date of the currently available and most commonly used 
cardiac output monitoring devices. In addition, an inte-
grated approach for the use of these diﬀ  erent devices in 
critically ill patients will be presented taking into con-
sidera  tion the devices’ technical characteristics, their 
perfor  mance and typical limitations, and also any addi-
tional hemodynamic variables they may oﬀ  er.
Overview of cardiac output monitoring devices
When selecting a cardiac output monitoring device for 
clinical use, diﬀ  erent factors play a role (Table 1): Institu-
tional factors may largely limit the choice of the available 
devices. On the other hand important device-related 
factors, e.g., invasiveness (Fig. 1), may restrict the area of 
application. Moreover, patient speciﬁ   c conditions may 
dictate the use of an invasive or a particular minimally- 
or non-invasive device.
Invasive cardiac output monitoring
Th  e PAC was the clinical standard for cardiac output 
monitoring for more than 20 years and the technique has 
been extensively investigated. Its complications are well 
known and despite developments in recent years, the 
PAC has a distinct role in patient care. An in-depth 
review is beyond the scope of this article, but some 
technical aspects and limitations need to be noted: 
Cardiac output measurement by intermittent pulmonary 
artery thermodilution, which is based on the Stewart-
Hamilton principle, is considered to be the `reference 
cardiac output monitoring standard’ against which all 
new cardiac output measuring devices are compared. 
How  ever, operator dependence, various patient condi-
tions (e.g., mitral or tricuspid valve insuﬃ   ciency, shunt) 
or misplacement of the PAC may inﬂ  uence  reliable 
cardiac output assessment [6]. In contrast, continuous 
cardiac output assessment may overcome some of these 
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under the German Copyright Law.limitations. Intermittent thermal ﬁ   lament heating in-
duces pulmonary artery temperature changes that are 
measured via a distal thermistor and matched with the 
input signal. Based on the cross correlation of in- and 
output signals intermittent cardiac output values are 
produced from a thermodilution wash-out curve. Th  ese 
values are then averaged for the display of continuous 
cardiac output readings, which results in a delayed 
response time of several minutes after induction of 
cardiac output changes (e.g., for Opti-QTM, Abbott, 
Abbott Park, IL and VigilanceTM catheters, Edwards 
LifeSiences, Irvine, CA) [7]. A so-called fast response 
continuous cardiac output catheter (truCCOMSTM, 
Omega Critical Care, East Klibride, GB) allows a more 
synchronized continuous cardiac output monitoring [8]. 
Th  e additional hemodynamic variables that can be 
assessed via PAC and are most often used are con-
ventional ﬁ  lling pressures, pulmonary artery pressures, 
and mixed venous oxygen saturation (SvO2). Th  erefore, 
the PAC is still indicated when additional monitoring of 
pulmonary artery pressures and SvO2 is desirable. It is 
also indicated in situations where less invasive techniques 
are contraindicated or fail to provide accurate cardiac 
output values.
Minimally invasive cardiac output monitoring
Minimally invasive cardiac output monitoring devices 
use one of four main principles to measure cardiac 
output: Pulse contour analysis, pulsed Doppler tech  no-
logy, applied Fick principle, and bioimpedance/bio-
reactance. Furthermore, devices that use pulse contour 
analysis can also be classiﬁ   ed into calibrated and 
uncalibrated systems.
Pulse pressure analysis
Pulse pressure analysis is based on the principle that SV 
can be continuously estimated by analyzing the arterial 
pressure waveform obtained from an arterial line. Th  e 
characteristics of the arterial pressure waveform are 
aﬀ  ected by the interaction between SV and individual 
vascular compliance, aortic impedance and peripheral 
arterial resistance. For reliable cardiac output measure-
ment using all devices that employ pulse pressure analysis 
technology, optimal arterial waveform signal (i.e., 
eliminating damping or increased tubing resonance) is a 
prerequisite. Moreover, it cannot be overemphasized that 
severe arrhythmias may reduce the accuracy of cardiac 
output measurement, and that the use of an intra-aortic 
balloon pump precludes adequate performance of the 
device. Furthermore, pulse pressure analysis may be of 
Table 1. Factors aff  ecting selection of cardiac output 
monitoring devices
Factor groups  Examples
Institution  Type of institution
  Availability of monitoring techniques
  Level of standardization
  Potential of integration into existing monitoring systems
  Level of experience
Devices Invasiveness
 Handling
 Technical  limitations
  Validity, accuracy & repeatability
  Availability of additional hemodynamic information
Patient  Severity of specifi  c diseases
 Heart  rhythm
 Contraindications
  Type of intervention
  Type of treatment protocol
Figure 1. Overview of cardiac output monitoring techniques. PAC: pulmonary artery catheter.
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instability, i.e., rapid changes in vascular resistance. Th  is 
may especially be a problem for uncalibrated pulse 
pressure analysis. In contrast, calibrated pulse pressure 
analysis may require frequent re-calibration for accurate 
cardiac output estimation in these situations. A growing 
number of calibrated and uncalibrated devices that 
measure the cardiac output based on the pulse pressure 
analysis method are available.
PiCCOplusTM system (Pulsion Medical Systems, 
Munich, Germany): Th  e  PiCCOTM system uses a 
dedicated thermistor-tipped catheter, which is typically 
placed in the femoral artery, in order to assess SV on a 
beat-to-beat basis. Alternatively a radial or brachial 
catheter may be employed, but these catheters have to be 
longer than the femoral one for the adequate assessment 
of the aortic arterial pressure wave signal. Cardiac output 
calibration via transpulmonary thermodilution requires 
the insertion of a central venous line. Th  e calibration 
process is also used for the adjustment of individual 
aortic impedance and needs to be repeated every eight 
hours in hemo  dynamically stable patients. However, 
during situations of hemodynamic instability, calibration 
needs to be done more frequently (eventually every hour) 
[9]. Nevertheless, a variety of studies have successfully 
validated the PiCCOplusTM system in diﬀ  erent patient 
populations [10,11].
Th  e launch of an uncalibrated device from Pulsion 
Medical Systems, the PulsioFlexTM system, can be 
expected in 2011. Th  e system will require a speciﬁ  c 
additional sensor, which can be connected to a regular 
invasive arterial pressure monitoring set.
LiDCOTMplus and LiDCOTMrapid system: Th  e 
LiDCOTMplus and LiDCOTMrapid systems (LiDCO Ltd, 
London, UK) use the same pulse pressure algorithm 
(PulseCOTM) to track continuous changes in SV. Th  is 
algorithm is based on the assumption that the net power 
change in the system in a heartbeat is the diﬀ  erence 
between the amount of blood entering the system (SV) 
and the amount of blood ﬂ  owing out peripherally. It uses 
the principle of conservation of mass (power) and 
assumes that following correction for compliance there is 
a linear relationship between netpower and netﬂ  ow. 
Th  erefore, the LiDCO systems should be considered as 
pulse power analysis techniques. Th  e LiDCOTMplus 
requires calibration using the transpulmonary lithium 
indicator dilution technique, which can be performed via 
a peripheral venous line [12]. In contrast, the 
LiDCOTMrapid uses nomograms for cardiac output 
estimation. Clinical studies have demonstrated reliable 
estimation of cardiac output using PulseCO as long as no 
major hemodynamic changes are observed [13]. Regard-
ing the LiDCOTMplus, the reliability of the lithium 
calibra  tion system may be negatively aﬀ   ected by high 
peak doses of muscle relaxants, which cross-react with 
the lithium sensor. Th  is can be tackled if the lithium 
calibration is performed before or 30 minutes after the 
administration of a muscle relaxant. Th  e LiDCOTMplus 
system, in combination with a hemodynamic treatment 
protocol (targeting an oxygen delivery > 600 ml/min/m2, 
was shown to be associated with reduced complications 
and length of hospital stay in patients after major general 
surgery [14]. Th   e primary indication for the uncalibrated 
LiDCOTMrapid is its perioperative use for SV 
optimization. Th  erefore, the LiDCOrapid trend analysis 
is more important than absolute cardiac output values 
(which may diﬀ  er when compared with cardiac output 
assessed by PAC).
FloTracTM/VigileoTM system:  Th  e FloTracTM/VigileoTM 
system (Edwards LifeSciences, Irvine, USA)  requires a 
proprietary transducer, the FloTracTM, which is attached 
to a standard non-proprietary radial or femoral arterial 
catheter and is connected to the VigileoTM monitor. Th  e 
FloTracTM/VigileoTM system does not require calibration. 
To estimate cardiac output, the standard deviation of 
pulse pressure sampled during a time window of 
20 seconds is correlated with `normal’ SV based on the 
patient’s demographic data (age, sex, height, and weight) 
and a built-in database containing information about 
cardiac output assessed by the PAC in a variety of clinical 
scenarios. Impedance is also derived from these data, 
whereas vascular compliance and resistance are deter-
mined using arterial waveform analysis. After conﬂ  icting 
results of early validation studies, the cardiac output 
algorithm has been repeatedly modiﬁ   ed in the last 
5 years. Th  is has resulted in an improved performance 
primarily in perioperative setting [15,16]. Further soft-
ware modiﬁ   cations addressed the issue of limited 
accuracy during hyperdynamic situations and prelimi-
nary data showed improved cardiac output measure  ments 
under these speciﬁ  c conditions. However, accuracy of the 
device during rapid hemodynamic changes remains a 
major concern [17]. Nevertheless, a study using the 
FlotracTM/VigileoTM system for intraoperative hemody-
namic optimization recently demonstrated a decreased 
complication rate and a reduced length of hospital stay 
[18].
A new cardiac output monitoring device based on 
pulse pressure analysis, which is calibrated by trans-
pulmonary thermodilution – the EV 1000TM/VolumeViewTM 
system from Edwards Lifesciences – is currently being 
tested and will soon be released for its use in daily 
practice.
Pressure recording analytical method (PRAM): Another 
method to estimate SV continuously without calibration 
is the PRAM – MostCare® (Vytech, Padova, Italy), which 
is based on mathematical assessment of the pressure 
signal obtained from an arterial line without calibration. 
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under various hemodynamic states [19] and in humans 
undergoing cardiac surgery [20]. Similar to other devices 
that use pulse contour analysis, the accuracy of PRAM-
derived cardiac output is aﬀ  ected by the quality of the 
pressure signal and by factors that interfere with the 
ability to detect a pressure signal.
Nexﬁ  nTM: Th  e  Nexﬁ  nTM HD (BMEYE B.V, Amsterdam, 
Netherlands) is a completely non-invasive pulse pressure 
analysis device that assesses pulse pressure using 
photoelectric plethysmography in combination with a 
volume-clamp technique (inﬂ  atable ﬁ  nger cuﬀ  ). Cardiac 
output is derived using the so-called Modelﬂ  ow method 
(simulation of a three-element Windkessel model). 
Regarding validation of the device, only limited published 
data are available [21].
Doppler cardiac output monitoring devices
Cardiac output can be estimated non-invasively using 
esophageal or transthoracic Doppler probes. Esophageal 
Doppler devices measure blood ﬂ  ow in the descending 
aorta and estimate cardiac output by multiplying the 
cross sectional area of the aorta by blood ﬂ  ow velocity. 
Th  e aortic diameter is obtained from a built-in nomo-
gram or by direct measurement using M-mode echo-
cardiography. Several esophageal Doppler probes are 
available commercially: ODM IITM (Abbott, Maiden  head, 
UK), CardioQTM (Deltex Medical Ltd, Chichester, Sussex, 
UK), and HemoSonic100TM (Arrow, Reading, PA, USA). 
Th   e latter device is a combination of a Doppler and an M-
mode probe, the production of which has been stopped 
recently. Th  ere are several limitations for the use of 
esophageal Doppler devices. First, the device measures 
blood ﬂ   ow in the descending aorta and makes an 
assumption of a ﬁ   xed partition between ﬂ   ow to the 
cephalic vessels and to the descending aorta. Although 
this may be valid in healthy volunteers, this relationship 
may change in patients with co-morbidities and under 
conditions of hemodynamic instability. Second, Doppler 
probes are smaller than conventional transesophageal 
echocardiography probes and position may change 
unintentionally, thus limiting continuous cardiac output 
assessment. Since probe position is crucial to obtaining 
an accurate measurement of aortic blood ﬂ  ow, this device 
is operator-dependent and studies have shown that 10–
12 insertions are required to obtain accurate measure-
ments [22] with an intra- and inter-observer variability of 
8–12% [23]. Moreover, aortic cross-sectional area is not 
constant but rather dynamic in any individual patient. 
Th   us, the use of a nomogram may result in less accurate 
cardiac output estimation. Despite some limitations of 
esophageal Doppler devices, their utility appears to be 
conﬁ  rmed by several perioperative hemodynamic opti-
mi  zation studies that have consistently demonstrated a 
reduction in complication rates and hospital length of 
stay [24].
Alternatively to the esophageal route, the transthoracic 
approach may be used to assess cardiac output, albeit 
intermittently. Th  e USCOMTM device (USCOM, Sidney, 
Australia) targets the pulmonary and aortic valves 
accessed via the parasternal and suprasternal windows in 
order to assess cardiac output completely non-invasively. 
Validation studies have revealed conﬂ  icting  results, 
which could be explained primarily by the inherent 
problem of variable signal detection [25,26].
Applied Fick principle
Partial CO2 rebreathing: Th  e NICOTM system (Nova-
metrix Medical Systems, Wallingford, USA) applies Fick 
principle to carbon dioxide (CO2) in order to obtain 
cardiac output measurement in intubated, sedated, and 
mechanically ventilated patients using a proprietary 
disposable re-breathing loop that is attached to the venti-
lator circuit. Th  e NICOTM system consists of a main-
stream infrared sensor to measure CO2, a disposable 
airﬂ  ow sensor, and a pulse oximeter. CO2 production is 
calculated as the product of CO2  concentration and 
airﬂ  ow during a breathing cycle, whereas arterial CO2 
content is derived from end-tidal CO2 and its corres-
ponding dissociation curve. Every three minutes, a partial 
re-breathing state is generated using the attached re-
breathing loop, which results in an increased end-tidal 
CO2 and reduced CO2 elimination. Assuming that cardiac 
output does not change signiﬁ  cantly between normal and 
re-breathing states, the diﬀ  erence between normal and 
re-breathing ratios are used to calculate cardiac output. 
Th   ere are several limitations to this device including the 
need for intubation and mechanical ventilation with ﬁ  xed 
ventilator settings and minimal gas exchange abnor  mali-
ties [27]. Variations in ventilator settings, mechanically-
assisted spontaneous breathing, the presence of increased 
pulmonary shunt fraction, and hemodynamic instability 
have been associated with decreased accuracy [28]. Th  us, 
this technique may be applied in a precisely deﬁ  ned 
clinical setting to mechanically ventilated patients only.
Pulsed dye densitometry: Th  e DDG-330® analyzer 
(Nihon Kohden, Tokyo, Japan) allows intermittent cardiac 
output measurement based on transpulmonary dye dilu-
tion with transcutaneous signal detection adapted from 
pulse oximetry (pulsed dye densitometry): Th  e concen-
tration of indocyanine green (ICG) is estimated in the 
arterial blood ﬂ  ow by optical absorbance measurements 
after its venous injection. Cardiac output is calculated 
from the dye dilution curve according to the Stewart-
Hamilton principle. Unfortunately a variety of factors, 
e.g., vasoconstriction, interstitial edema, movement or 
ambient light artefacts, may limit reliable intermittent 
cardiac output assessment [29].
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Electrical bioimpedance uses electric current stimulation 
for identiﬁ  cation of thoracic or body impedance varia-
tions induced by cyclic changes in blood ﬂ  ow caused by 
the heart beating. Cardiac output is continuously esti-
mated using skin electrodes (BioZ®, CardioDynamics, 
San Diego, USA) or electrodes mounted on an endo-
tracheal tube (ECOMTM, Conmed Corp, Utica, USA) by 
analyzing the occurring signal variation with diﬀ  erent 
mathematical models. Despite many adjustments of the 
mathematical algorithms, clinical validation studies 
continue to show conﬂ  icting results [30,31].
Recently, however, Bioreactance® (NICOM®, Cheetah 
Medical Ltd, Maidenhead, Berkshire, UK) a modiﬁ  cation 
of thoracic bioimpedance, has been introduced [32]. In 
contrast to bioimpedance, which is based on the analysis 
of transthoracic voltage amplitude changes in response to 
high frequency current, the Bioreactance® technique 
analyzes the frequency spectra variations of the delivered 
oscillating current. Th   is approach is supposed to result in 
a higher signal-to-noise ratio and thus in an improved 
performance of the device. In fact, initial validation 
studies reveal promising results [32,33].
Additional hemodynamic variables
Apart from SV and cardiac output, hemodynamic monit-
oring devices provide various additional hemodynamic 
variables (Table 2); namely, static preload variables, func-
tional hemodynamic variables, and continuous central 
venous oxygen saturation (ScvO2).
Static preload variables
Various cardiac output monitoring devices require a 
central venous line for calibration of the system. Th  us, 
central venous pressure (CVP) is brieﬂ  y reviewed here. 
CVP is traditionally assessed as an estimate of cardiac 
preload since true preload, which is deﬁ   ned as end-
diastolic myocardial ﬁ  ber tension, cannot be measured at 
the bedside. Several factors, however, aﬀ  ect CVP read-
ings including impaired right ventricular (RV) func  tion, 
and severe pulmonary or valvular heart disease. Although 
the majority of physicians use CVP in order to guide ﬂ  uid 
therapy [34], several studies have shown lack of 
correlation between CVP and SV [35,36]. Moreover, 
absolute CVP cannot be used to assess preload res-
ponsive ness.  Th   erefore, the utility of CVP is limited and 
changes in trend over time and cyclic changes induced by 
mechanical ventilation are more important than absolute 
numbers. In contrast to the pressure preload variables, 
the so-called volumetric preload variables are considered 
to be superior indicators of preload. Global end-diastolic 
volume (GEDV) and extravascular lung water (EVLW) 
are static volumetric parameters that are assessed by 
transpulmonary thermodilution, which is required for 
the calibration of the PiCCOplus device and the up-
coming EV1000/VolumeView device. Diﬀ  erent  studies 
have shown a better correlation between GEDV and SV 
than between the latter and static pressure preload [35]. 
GEDV could thus be used to better guide perioperative 
ﬂ   uid therapy than pressure preload parameters [37]. 
EVLW on the other hand can be used to diﬀ  erentiate 
between cardiac versus non-cardiac pulmonary edema, 
and has been identiﬁ  ed as an independent predictor of 
survival in critically ill patients [38]. It may, therefore, be 
of value in tailoring therapy in patients with acute 
respiratory distress syndrome (ARDS).
Functional hemodynamic variables
Pulse pressure analysis devices provide an automated 
quantiﬁ  cation of SV variation (SVV) and some also allow 
the determination of pulse pressure variation (PPV). Th  e 
basis of these functional variables is cyclic changes in 
intrathoracic pressure during positive pressure venti-
lation which induce changes in SV and pulse pressure as 
a result of a reduction in preload. Th  e  diﬀ  erent functional 
hemodynamic variables have been shown to be able to 
predict ﬂ   uid responsiveness in various studies [39], 
whereas static preload variables have not [40]. None-
theless, it has to be emphasized that cardiovascular and 
ventilatory limitations, such as arrhythmias, right heart 
failure, spontaneous breathing activity, and low tidal 
volume (< 8 ml/kg body weight) aﬀ  ect the reliability of 
these dynamic indices of ﬂ   uid responsiveness. Under 
these circumstances, `passive leg raising’ could be em-
ployed to assess ﬂ  uid responsiveness as it results in an 
internal ﬂ  uid shift from the legs to the central compart-
ment caused by the modiﬁ   ed Trendelenburg position. 
Th   is technique has been demonstrated to reliably 
determine ﬂ   uid responsiveness in critically ill patients 
[41].
Central venous oxygen saturation
ScvO2 is used as a global marker of the balance between 
systemic oxygen supply and demand [42]. It can be easily 
measured by obtaining a blood sample drawn from a 
central venous catheter, compared with SvO2, which 
requires placement of a PAC and the withdrawal of blood 
from the distal port of the catheter. In addition to 
intermittent measurements using a blood sample and a 
blood gas analyzer, both ScvO2 and SvO2 can be 
measured continuously using proprietary central venous 
and pulmonary artery catheters, respectively. Th  ere are 
no outcome studies that compare intermittent versus 
continuous measurements of ScvO2 or SvO2; however, 
the only study that showed a survival beneﬁ  t using ScvO2 
as a resuscitation endpoint employed continuous 
measure  ment [43]. Using proprietary catheters, continu-
ous measurements of ScvO2 can be obtained from both 
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Additional variables
Groups Examples Features Invasiveness
Continuous 
CO Static Dynamic SvO2/ScvO2
PAC
VigilanceTM Right heart 
catheterization
 Response 
time up to 
12 minutes
CVP 
PCWP
– Specifi  c catheter 
for continuous 
measurement 
available
Pulse wave 
analysis
Calibrated PiCCOplusTM Thermistor-tipped 
arterial catheter 
Central venous 
line
 Response time 
3 seconds
CVP 
GEDV 
EVLW
SVV 
PPV
Specifi  c catheter 
for continuous 
measurement 
available
LiDCOplusTM Lithium dilution 
set
 Beat-by-beat – SVV 
PPV
–
EV1000TM/ 
VolumeViewTM*
Thermistor-tipped 
arterial catheter 
Central venous 
line
 NA CVP 
GEDV 
EVLW
SVV Specifi  c catheter 
for continuous 
measurement 
available
Uncalibrated FloTrac/VigileoTM Specifi  c arterial 
pressure sensor
 Response time 
20 seconds
– SVV Specifi  c catheter 
for continuous 
measurement 
available
LiDCOrapidTM Regular arterial 
line
 Beat-by-beat – SVV 
PPV
–
PulsioFlexTM* Regular arterial 
line Specifi  c 
sensor
 NA – SVV 
PPV
Specifi  c catheter 
for continuous 
measurement 
available
PRAM MostCare® Specifi  c arterial kit  Beat-by-beat – SVV 
PPV
–
Nexfi  nTM HD Specifi  c pressure 
sensors
 Beat-by-beat – – –
Doppler
TE CardioQTM Esophageal 
Flowprobe
 Limitation: 
probe 
positioning
–– –
TT USCOMTM Flowprobe   Intermittent – – –
Applied Fick 
principle
Partial CO2 
rebreathing
NiCOTM Rebreating  loop  Up-date 
every 3’
–– –
Dye dilution DDG analyzer® Specifi  c sensor   Intermittent – – –
Bioimpedance/
Bioreactance
Endotracheal 
bioimpedance
ECOMTM Specifi  c 
endotracheal 
tube, arterial line
 Continuous – – –
Thoracic/
whole body 
bioimpedance
BioZ® Specifi  c 
electrodes
 Continuous – – –
Thoracic 
bioreactance
NICOMTM Specifi  c 
electrodes
 Continuous – SVV –
CO: cardiac output; CVP: central venous pressure; EVLW: extravascular lung water; GEDV: global end-diastolic volume; NA: technical specifi  cations not yet available; 
PAC: pulmonary artery catheter; PAOP: pulmonary artery occlusion pressure; PPV: pulse pressure variation; SvO2: mixed venous oxygen saturation; ScvO2; central 
venous oxy gen saturation; SVV; stroke volume variation; TE: transesophageal; TT: transthoracic; *not yet available.
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clinical utility is concerned, ScvO2 has been used as a 
resuscitation endpoint in patients with severe sepsis and 
septic shock [43]. It is important to realize that absolute 
ScvO2 and SvO2 values may diﬀ   er considerably in 
diﬀ  erent clinical situations; however, a strong correlation 
of their trends over time has been demonstrated [44].
Integrative concept
Considering the technical features and the typical 
limitations of the diﬀ   erent cardiac output monitoring 
techniques it is obvious that no single device can comply 
with all clinical requirements. Th  erefore,  diﬀ  erent devices 
may be used in an integrative concept along a typical 
clinical patient pathway (Fig. 2) based on the invasiveness 
of the devices and the available additional hemodynamic 
variables (Table 2). Bioreactance may be used on the 
ward or in the emergency department to assess cardiac 
output initially in order to conﬁ   rm a preliminary 
diagnosis. Its use may be expanded in the perioperative 
and ICU setting. Partial CO2-rebreathing requires an 
intubated and mechanically ventilated patient for cardiac 
output estimation. Th   us, this technique may be primarily 
used during an operation. Uncalibrated pulse pressure 
analysis devices may be the primary choice in a 
perioperative setting as they provide functional hemo-
dynamic variables and thus allow comprehensive hemo-
dy  namic management. In contrast, calibrated systems 
may be required when postoperative complications or 
hemodynamicinstability occur and increased device 
accuracy or volumetric variables are needed for improved 
patient management. In the presence of factors that aﬀ  ect 
the accuracy of all minimally invasive cardiac output 
monitoring devices, or when pulmonary artery pressure 
monitoring or right heart failure treatment is required, 
PAC insertion may be required for patient speciﬁ  c 
therapy.
Conclusion
Various devices that allow continuous cardiac output 
measurement in the critically ill patient are commercially 
available today. Th  eir presence does not completely 
preclude but does increasingly limit the use of the PAC. 
A variety of factors (institutional, device related, and 
patient speciﬁ  c)  inﬂ   uence the selection of a cardiac 
output monitoring device and clinicians need to under-
stand the underlying principles and the inherent limita-
tions of these devices. A selection of these techniques 
may be used in an integrative approach along a patient 
pathway. In combination with ScvO2 measurements, the 
assessment of volumetric preload variables and the 
functional hemodynamic variables that they provide may 
obviate the need for a PAC in the treatment of critically 
ill patients.
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